Clinical Trial Update: Multiple Dose-escalation Study of AMA0076 in Patients With Ocular Hypertension or Primary Open-angle Glaucoma [Phase 2]

View source ↗

Summary

This document reports the completion of a Phase 2 multiple-dose escalation study of AMA0076 in patients with glaucoma or ocular hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Hypertension

Drugs mentioned

• AMA0076

Snippet

Sponsor: Amakem, NV | Conditions: Glaucoma, Ocular Hypertension | Phase 2 | Status: COMPLETED